These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31478563)

  • 1. Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth.
    Tokumoto H; Setoguchi T; Saitoh Y; Sasaki H; Nagano S; Maeda S; Tanimoto A; Taniguchi N
    Mol Carcinog; 2019 Dec; 58(12):2230-2240. PubMed ID: 31478563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells.
    Zhang Y; Zhu S; Yi L; Liu Y; Cui H
    Mol Cell Biochem; 2014 Apr; 389(1-2):1-8. PubMed ID: 24357116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.
    Moody TW; Chan DC; Mantey SA; Moreno P; Jensen RT
    Life Sci; 2014 Mar; 100(1):25-34. PubMed ID: 24496038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.
    Ouyang Q; Gong X; Xiao H; Zhou J; Xu M; Dai Y; Xu L; Feng H; Cui H; Yi L
    Mol Cancer; 2015 Feb; 14():21. PubMed ID: 25644759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma.
    Dong Z; Lei Q; Yang R; Zhu S; Ke XX; Yang L; Cui H; Yi L
    Br J Cancer; 2017 Jun; 116(12):1572-1584. PubMed ID: 28494471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer.
    Liu J; Agopiantz M; Poupon J; Wu Z; Just PA; Borghese B; Ségal-Bendirdjian E; Gauchotte G; Gompel A; Forgez P
    Clin Cancer Res; 2017 Nov; 23(21):6516-6528. PubMed ID: 28790113
    [No Abstract]   [Full Text] [Related]  

  • 7. The histone deacetylase inhibitor LBH589 inhibits undifferentiated pleomorphic sarcoma growth via downregulation of FOS-like antigen 1.
    Saitoh Y; Bureta C; Sasaki H; Nagano S; Maeda S; Furukawa T; Taniguchi N; Setoguchi T
    Mol Carcinog; 2019 Feb; 58(2):234-246. PubMed ID: 30303565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
    Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
    Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin receptor 1 signaling promotes pancreatic cancer progression.
    Takahashi K; Ehata S; Miyauchi K; Morishita Y; Miyazawa K; Miyazono K
    Mol Oncol; 2021 Jan; 15(1):151-166. PubMed ID: 33034134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
    Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
    Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer.
    Akter H; Yoon JH; Yoo YS; Kang MJ
    Mol Cells; 2018 Jun; 41(6):591-602. PubMed ID: 29794962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference with NTSR1 Expression Exerts an Anti-Invasion Effect via the Jun/miR-494/SOCS6 Axis of Glioblastoma Cells.
    Ou-Yang Q; He X; Yang A; Li B; Xu M
    Cell Physiol Biochem; 2018; 49(6):2382-2395. PubMed ID: 30261490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Positive Feedback Loop Between NTSR1 and Wnt/β-Catenin Contributes to Tumor Growth of Glioblastoma.
    Xiao H; Zeng Y; Wang Q; Wei S; Zhu X
    Cell Physiol Biochem; 2017; 43(5):2133-2142. PubMed ID: 29065410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heightened amygdala long-term potentiation in neurotensin receptor type-1 knockout mice.
    Amano T; Wada E; Yamada D; Zushida K; Maeno H; Noda M; Wada K; Sekiguchi M
    Neuropsychopharmacology; 2008 Dec; 33(13):3135-45. PubMed ID: 18354386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Silico Investigation of the Neurotensin Receptor 1 Binding Site: Overlapping Binding Modes for Small Molecule Antagonists and the Endogenous Peptide Agonist.
    Lückmann M; Holst B; Schwartz TW; Frimurer TM
    Mol Inform; 2016 Jan; 35(1):19-24. PubMed ID: 27491650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation.
    Valerie NC; Casarez EV; Dasilva JO; Dunlap-Brown ME; Parsons SJ; Amorino GP; Dziegielewski J
    Cancer Res; 2011 Nov; 71(21):6817-26. PubMed ID: 21903767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
    Kim JT; Weiss HL; Evers BM
    Int J Oncol; 2017 Jun; 50(6):2200-2206. PubMed ID: 28498396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labeling the Stroma of a Patient-Derived Orthotopic Xenograft (PDOX) Mouse Model of Undifferentiated Pleomorphic Soft-Tissue Sarcoma With Red Fluorescent Protein for Rapid Non-Invasive Imaging for Drug Screening.
    Kiyuna T; Murakami T; Tome Y; Igarashi K; Kawaguchi K; Russell T; Eckardt MA; Crompton J; Singh A; Bernthal N; Bukata S; Federman N; Kanaya F; Eilber FC; Hoffman RM
    J Cell Biochem; 2017 Feb; 118(2):361-365. PubMed ID: 27357060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of NTSR1 on the Proliferation and Invasion of Gastric Adenocarcinoma Cells, the Underlying Mechanism, and Clinical Role.
    Wang H; Huang D; Zhou Z
    Ann Clin Lab Sci; 2021 Mar; 51(2):163-173. PubMed ID: 33941555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of neurotensin receptor 1 as potential biomarker for prostate cancer theranostic use.
    He T; Wang M; Wang H; Tan H; Tang Y; Smith E; Wu Z; Liao W; Hu S; Li Z
    Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2199-2207. PubMed ID: 31264168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.